(Q52900179)

9 May 2018

title

Summing up evidence: one answer is not always enough. (English)

1 reference

9 May 2018

author

Christopher H. Schmid

series ordinal

3

1 reference

9 May 2018

author name string

J Lau

series ordinal

1

1 reference

9 May 2018

J P Ioannidis

series ordinal

2

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

9 May 2018

published in

The Lancet

1 reference

9 May 2018

volume

351

1 reference

9 May 2018

issue

9096

1 reference

9 May 2018

page(s)

123-127

1 reference

9 May 2018

Meta-analytic stimulus for changes in clinical trials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Publication bias and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Answers to complex questions cannot be derived from "simple" trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Exploratory or analytic meta-analysis: should we distinguish between them?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

The case for failed meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Bayesian approaches to random-effects meta-analysis: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

On meta-analyses of meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Trial of Calcium to Prevent Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Predictive ability of meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Large trials vs meta-analysis of smaller trials: how do their results compare?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Cholesterol lowering and mortality: the importance of considering initial level of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

An effect model for the assessment of drug benefit: example of antiarrhythmic drugs in postmyocardial infarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Uses of ecologic analysis in epidemiologic research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Why do we need some large, simple randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

The population risk as an explanatory variable in research synthesis of clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

The relation between treatment benefit and underlying risk in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

The impact of high-risk patients on the results of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Mega-trials and management of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

An evidence based approach to individualising treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Meta-analysis of Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Changes in clinical trials mandated by the advent of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908468-7

7 January 2021

10.1016/S0140-6736(97)08468-7

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018